| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RMD
|
33.04 | 4.8B | 2.20 | 0.52 | 1.16 | 23.8% | 9.2% | 87 | 86 | 99.12 | +150.0% | 94 | 0.13 |
|
SHL
|
19.59 | 9.7B | 18.85 | 1.16 | 8.41 | 6.6% | 8.2% | 67 | 52 | 32.08 | +45.9% | 56 | 0.62 |
|
CSL
|
171.57 | 82.2B | 19.13 | 2.97 | 13.00 | 9.7% | 8.4% | 62 | 46 | 164.74 | -2.9% | 70 | 0.59 |
|
COH
|
133.92 | 8.8B | 22.52 | 4.49 | 14.06 | 19.9% | 10.8% | 54 | 43 | 83.73 | -28.1% | 96 | 0.12 |
|
PME
|
176.42 | 18.4B | 100.00 | 71.72 | 110.76 | 172.4% | 10.0% | 48 | 36 | 44.10 | -56.2% | 100 | 0.01 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.